-
2
-
-
84876756293
-
The association of diabetes with breast cancer incidence and mortality in the long island breast cancer study project
-
Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI,Gammon MD. The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control. 2012;1:1-11.
-
(2012)
Cancer Causes Control
, vol.1
, pp. 1-11
-
-
Cleveland, R.J.1
North, K.E.2
Stevens, J.3
Teitelbaum, S.L.4
Neugut, A.I.5
Gammon, M.D.6
-
3
-
-
2942520997
-
Diabetes mellitus as a predictor of cancer mortality in a large cohort of us adults
-
Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004;159:1160-1167.
-
(2004)
Am J Epidemiol
, vol.159
, pp. 1160-1167
-
-
Coughlin, S.S.1
Calle, E.E.2
Teras, L.R.3
Petrelli, J.4
Thun, M.J.5
-
4
-
-
79951991748
-
Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer
-
Erickson K, Patterson RE, Flatt SW, et al. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. J Clin Oncol. 2011;29:54-60.
-
(2011)
J Clin Oncol
, vol.29
, pp. 54-60
-
-
Erickson, K.1
Patterson, R.E.2
Flatt, S.W.3
-
5
-
-
79951960884
-
Diabetes mellitus and breast cancer outcomes: A systematic review and meta-Analysis
-
Peairs KS, Barone BB, Snyder CF, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-Analysis. J Clin Oncol. 2011;29:40-46.
-
(2011)
J Clin Oncol
, vol.29
, pp. 40-46
-
-
Peairs, K.S.1
Barone, B.B.2
Snyder, C.F.3
-
6
-
-
84870244963
-
Epidemiological evidence of a relationship between type-1 diabetes mellitus and cancer: A review of the existing literature
-
Gordon-Dseagu VL, Shelton N, Mindell JS. Epidemiological evidence of a relationship between type-1 diabetes mellitus and cancer: a review of the existing literature. Int J Cancer. 2013;132:501-508.
-
(2013)
Int J Cancer
, vol.132
, pp. 501-508
-
-
Gordon-Dseagu, V.L.1
Shelton, N.2
Mindell, J.S.3
-
7
-
-
0030871903
-
Cancer and diabetes -A follow-up study of two population-based cohorts of diabetic patients
-
Hjalgrim H, Frisch M, Ekbom A, Kyvik K, Melbye M, Green A. Cancer and diabetes -A follow-up study of two population-based cohorts of diabetic patients. J Int Med. 1997;241:471-475.
-
(1997)
J Int Med
, vol.241
, pp. 471-475
-
-
Hjalgrim, H.1
Frisch, M.2
Ekbom, A.3
Kyvik, K.4
Melbye, M.5
Green, A.6
-
8
-
-
77954249988
-
Cancer risk among patients hospitalized for type 1 diabetes mellitus: A population-based cohort study in sweden
-
Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med. 2010;27:791-797.
-
(2010)
Diabet Med
, vol.27
, pp. 791-797
-
-
Shu, X.1
Ji, J.2
Li, X.3
Sundquist, J.4
Sundquist, K.5
Hemminki, K.6
-
9
-
-
0031984686
-
Insulin and related factors in premenopausal breast cancer risk
-
Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ. Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat. 1998;47:111-120.
-
(1998)
Breast Cancer Res Treat
, vol.47
, pp. 111-120
-
-
Del Giudice, M.E.1
Fantus, I.G.2
Ezzat, S.3
McKeown-Eyssen, G.4
Page, D.5
Goodwin, P.J.6
-
10
-
-
3242746896
-
Hyperinsulinaemia and increased risk of breast cancer: Findings from the british women's heart and health study
-
Lawlor DA, Smith GD, Ebrahim S. Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control. 2004;15:267-275.
-
(2004)
Cancer Causes Control
, vol.15
, pp. 267-275
-
-
Lawlor, D.A.1
Smith, G.D.2
Ebrahim, S.3
-
11
-
-
84855426420
-
Hyperinsulinemia enhances c-myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes
-
Ferguson RD, Novosyadlyy R, Fierz Y, et al. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Breast Cancer Res. 2012;14:R8.
-
(2012)
Breast Cancer Res
, vol.14
-
-
Ferguson, R.D.1
Novosyadlyy, R.2
Fierz, Y.3
-
12
-
-
0028969852
-
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin
-
WuX, Fan Z, Masui H, Rosen N, Mendelsohn J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest. 1995;95:1897.
-
(1995)
J Clin Invest
, vol.95
, pp. 1897
-
-
WuX Fan, Z.1
Masui, H.2
Rosen, N.3
Mendelsohn, J.4
-
14
-
-
0031919552
-
Insulin signal transduction through protein kinase cascades
-
Avruch J. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem. 1998;182:31-48.
-
(1998)
Mol Cell Biochem
, vol.182
, pp. 31-48
-
-
Avruch, J.1
-
15
-
-
0036550234
-
Signalling through igf-i and insulin receptors: Where is the specificity?
-
Kim JJ, Accili D. Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm IGF Res. 2002;12:84-90.
-
(2002)
Growth Horm IGF Res
, vol.12
, pp. 84-90
-
-
Kim, J.J.1
Accili, D.2
-
17
-
-
77957241580
-
The proliferating role of insulin and insulin-like growth factors in cancer
-
Gallagher EJ, LeRoith D. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab. 2010; 21:610.
-
(2010)
Trends Endocrinol Metab
, vol.21
, pp. 610
-
-
Gallagher, E.J.1
LeRoith, D.2
-
18
-
-
0030679620
-
Insulin receptor expression and clinical outcome in node-negative breast cancer
-
MathieuMC,ClarkGM,Allred DC, Goldfine ID, Vigneri R. Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians. 1997;109:565.
-
(1997)
Proc Assoc Am Physicians
, vol.109
, pp. 565
-
-
Mathieu, M.C.1
Clark, G.M.2
Allred, D.C.3
Goldfine, I.D.4
Vigneri, R.5
-
20
-
-
76549136489
-
Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes
-
Novosyadlyy R, Lann DE, Vijayakumar A, et al. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res. 2010;70:741-751.
-
(2010)
Cancer Res
, vol.70
, pp. 741-751
-
-
Novosyadlyy, R.1
Lann, D.E.2
Vijayakumar, A.3
-
21
-
-
84863727860
-
Inhibiting pi3k reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
-
Gallagher E, Fierz Y, Vijayakumar A, Haddad N, Yakar S, LeRoith D. Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. Oncogene. 2012;31:3213-3222.
-
(2012)
Oncogene
, vol.31
-
-
Gallagher, E.1
Fierz, Y.2
Vijayakumar, A.3
Haddad, N.4
Yakar, S.5
LeRoith, D.6
-
22
-
-
7444250290
-
Mutation of the pik3ca gene in ovarian and breast cancer
-
Campbell IG, Russell SE, Choong DY, et al. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 2004;64: 7678-7681.
-
(2004)
Cancer Res
, vol.64
, pp. 7678-7681
-
-
Campbell, I.G.1
Russell, S.E.2
Choong, D.Y.3
-
23
-
-
0036632368
-
The phosphatidylinositol 3-kinase akt pathway in human cancer
-
Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489-501.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 489-501
-
-
Vivanco, I.1
Sawyers, C.L.2
-
24
-
-
84865585349
-
Identification of common and distinctive mechanisms of resistance to different anti-igf-ir agents in ewing's sarcoma
-
Garofalo C, Mancarella C, Grilli A, et al. Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma. Mol Endocrinol. 2012;26:1603-1616.
-
(2012)
Mol Endocrinol
, vol.26
-
-
Garofalo, C.1
Mancarella, C.2
Grilli, A.3
-
25
-
-
77953973648
-
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to igf-1r targeted therapy
-
Ulanet DB, Ludwig DL, Kahn CR, Hanahan D. Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci. 2010;107:10791-10798.
-
(2010)
Proc Natl Acad Sci
, vol.107
, pp. 10791-10798
-
-
Ulanet, D.B.1
Ludwig, D.L.2
Kahn, C.R.3
Hanahan, D.4
-
26
-
-
43349088787
-
Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
-
Yuen JSP, Macaulay VM. Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. Expert Opin Ther Targets. 2008;12:589-603.
-
(2008)
Expert Opin Ther Targets
, vol.12
, pp. 589-603
-
-
Yuen, J.S.P.1
Macaulay, V.M.2
-
27
-
-
1642494838
-
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
-
Girnita A, Girnita L, del Prete F, Bartolazzi A, Larsson O, Axelson M. Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth. Cancer Res. 2004;64:236-242.
-
(2004)
Cancer Res
, vol.64
, pp. 236-242
-
-
Girnita, A.1
Girnita, L.2
Del Prete, F.3
Bartolazzi, A.4
Larsson, O.5
Axelson, M.6
-
28
-
-
2942558349
-
Explant-cell culture of primary mammary tumors from mmtv-c-myc transgenic mice
-
Pei XF, Noble MS, Davoli MA, et al. Explant-cell culture of primary mammary tumors from MMTV-c-Myc transgenic mice. In Vitro Cell Dev Biol Anim. 2004;40:14-21.
-
(2004)
Vitro Cell Dev Biol Anim
, vol.40
, pp. 14-21
-
-
Pei, X.F.1
Noble, M.S.2
Davoli, M.A.3
-
29
-
-
0035425234
-
Functional inactivation of the igf-i and insulin receptors in skeletal muscle causes type 2 diabetes
-
FernándezAM,KimJK, Yakar S, et al. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev. 2001;15:1926-1934.
-
(2001)
Genes Dev
, vol.15
, pp. 1926-1934
-
-
Fernández, A.M.1
Kim, J.K.2
Yakar, S.3
-
30
-
-
84864917469
-
Cancer risk in type 2 diabetes mellitus: Metabolic links and therapeutic considerations
-
Sun G, Kashyap SR. Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations. J Nutr Metab. 2011; 2011:708183.
-
(2011)
J Nutr Metab
, vol.2011
, pp. 708183
-
-
Sun, G.1
Kashyap, S.R.2
-
31
-
-
58549084793
-
Insulin, insulin-like growth factor-i, and risk of breast cancer in postmenopausal women
-
Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2009;101:48-60.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 48-60
-
-
Gunter, M.J.1
Hoover, D.R.2
Yu, H.3
-
32
-
-
0036721523
-
Activation of themapkpathway enhances sensitivity ofmcf-7breast cancer cells to the mitogenic effect of estradiol
-
Yue W, Wang JP, Conaway M, Masamura S, Li Y, Santen RJ. Activation of theMAPKpathway enhances sensitivity ofMCF-7breast cancer cells to the mitogenic effect of estradiol. Endocrinology. 2002;143:3221-3229.
-
(2002)
Endocrinology
, vol.143
, pp. 3221-3229
-
-
Yue, W.1
Wang, J.P.2
Conaway, M.3
Masamura, S.4
Li, Y.5
Santen, R.J.6
-
33
-
-
79958272949
-
Mechanism of the mitogenic influence of hyperinsulinemia
-
Draznin B. Mechanism of the mitogenic influence of hyperinsulinemia. Diabetol Metab Syndr. 2011;3:10.
-
(2011)
Diabetol Metab Syndr
, vol.3
, pp. 10
-
-
Draznin, B.1
-
34
-
-
0014056238
-
Cell proliferation induced by insulin in organ culture of rat mammary carcinoma
-
Heuson JC, Coune A, Heimann R. Cell proliferation induced by insulin in organ culture of rat mammary carcinoma. Exp Cell Res. 1967;45:351-360.
-
(1967)
Exp Cell Res
, vol.45
, pp. 351-360
-
-
Heuson, J.C.1
Coune, A.2
Heimann, R.3
-
35
-
-
3543072186
-
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
-
Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579-591.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 579-591
-
-
Calle, E.E.1
Kaaks, R.2
-
36
-
-
0035138167
-
Reducing bioavailable sex hormones through a comprehensive change in diet: The diet and androgens (diana) randomized trial
-
Berrino F, Bellati C, Secreto G, et al. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev. 2001;10:25-33.
-
(2001)
Cancer Epidemiol Biomarkers Prev
, vol.10
, pp. 25-33
-
-
Berrino, F.1
Bellati, C.2
Secreto, G.3
-
37
-
-
0029970843
-
Nutrition, hormones, and breast cancer: Is insulin the missing link?
-
Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control. 1996;7:605-625.
-
(1996)
Cancer Causes Control
, vol.7
, pp. 605-625
-
-
Kaaks, R.1
-
38
-
-
0035961202
-
Breast cancer: Hormones and other risk factors
-
discussion 113-116
-
Hulka BS, Moorman PG. Breast cancer: hormones and other risk factors. Maturitas. 2001;38:103-113; discussion 113-116.
-
(2001)
Maturitas
, vol.38
, pp. 103-113
-
-
Hulka, B.S.1
Moorman, P.G.2
-
39
-
-
57149143868
-
Growth hormone and insulin-like growth factor-i in the transition from normal mammary development to preneoplastic mammary lesions
-
Kleinberg DL, Wood TL, Furth PA, Lee AV. Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocrine Rev. 2009;30:51-74.
-
(2009)
Endocrine Rev
, vol.30
, pp. 51-74
-
-
Kleinberg, D.L.1
Wood, T.L.2
Furth, P.A.3
Lee, A.V.4
-
41
-
-
33751290510
-
Classification of breast cancer using genetic algorithms and tissue microarrays
-
Dolled-Filhart M, Rydén L, Cregger M, et al. Classification of breast cancer using genetic algorithms and tissue microarrays. Clin Cancer Res. 2006;12:6459-6468.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6459-6468
-
-
Dolled-Filhart, M.1
Rydén, L.2
Cregger, M.3
-
42
-
-
33846425793
-
The prognostic role of a gene signature from tumorigenic breast-cancer cells
-
Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells.NEngl J Med. 2007; 356:217-226.
-
(2007)
NEngl J Med
, vol.356
, pp. 217-226
-
-
Liu, R.1
Wang, X.2
Chen, G.Y.3
-
43
-
-
52949099133
-
Anovel high-Affinity peptide antagonist to the insulin receptor
-
Schäffer L, Brand CL, Hansen BF, et al.Anovel high-Affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun. 2008;376:380-383.
-
(2008)
Biochem Biophys Res Commun
, vol.376
, pp. 380-383
-
-
Schäffer, L.1
Brand, C.L.2
Hansen, B.F.3
-
44
-
-
77955058188
-
S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats
-
Vikram A, Jena G. S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats. Biochem Biophys Res Commun. 2010;398:260-265.
-
(2010)
Biochem Biophys Res Commun
, vol.398
, pp. 260-265
-
-
Vikram, A.1
Jena, G.2
-
45
-
-
34047270772
-
Picropodophyllotoxin or podophyllotoxin does not induce cell death via insulin-like growth factor-i receptor
-
Linder S, Shoshan MC, Gupta RS. Picropodophyllotoxin or podophyllotoxin does not induce cell death via insulin-like growth factor-I receptor. Cancer Res. 2007;67:2899.
-
(2007)
Cancer Res
, vol.67
, pp. 2899
-
-
Linder, S.1
Shoshan, M.C.2
Gupta, R.S.3
-
46
-
-
77950354885
-
Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression
-
Fierz Y, Novosyadlyy R, Vijayakumar A, Yakar S, LeRoith D. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression. Diabetes. 2010;59:686-693.
-
(2010)
Diabetes
, vol.59
, pp. 686-693
-
-
Fierz, Y.1
Novosyadlyy, R.2
Vijayakumar, A.3
Yakar, S.4
LeRoith, D.5
-
47
-
-
33746257209
-
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
-
Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606-619.
-
(2006)
Nat Rev Genet
, vol.7
, pp. 606-619
-
-
Engelman, J.A.1
Luo, J.2
Cantley, L.C.3
-
48
-
-
78649816080
-
Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes
-
Fierz Y, Novosyadlyy R, Vijayakumar A, Yakar S, LeRoith D.Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes. Endocr Relat Cancer. 2010;17:941-951.
-
(2010)
Endocr Relat Cancer
, vol.17
, pp. 941-951
-
-
Fierz, Y.1
Novosyadlyy, R.2
Vijayakumar, A.3
Yakar, S.4
LeRoith, D.5
-
49
-
-
70849120946
-
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease
-
Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009;30:586-623.
-
(2009)
Endocr Rev
, vol.30
, pp. 586-623
-
-
Belfiore, A.1
Frasca, F.2
Pandini, G.3
Sciacca, L.4
Vigneri, R.5
-
50
-
-
33846458639
-
Down-regulation of type i insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
-
Zhang H, Pelzer AM, Kiang DT, Yee D. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Cancer Res. 2007;67:391-397.
-
(2007)
Cancer Res
, vol.67
, pp. 391-397
-
-
Zhang, H.1
Pelzer, A.M.2
Kiang, D.T.3
Yee, D.4
-
51
-
-
0029011218
-
The mapk signaling cascade
-
Seger R, Krebs E. The MAPK signaling cascade. FASEB J. 1995;9: 726-735.
-
(1995)
FASEB J
, vol.9
, pp. 726-735
-
-
Seger, R.1
Krebs, E.2
-
52
-
-
67749117934
-
Signal integration byjnkand p38mapk pathways in cancer development
-
Wagner EF, Nebreda AR. Signal integration byJNKand p38MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537-549.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 537-549
-
-
Wagner, E.F.1
Nebreda, A.R.2
-
53
-
-
56849114259
-
Oral picropodophyllin (ppp) is well tolerated in vivo and inhibits igf-1r expression and growth of uveal melanoma
-
Economou MA, Andersson S, Vasilcanu D, et al. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma. Acta Ophthalmol. 2008;86:35-41.
-
(2008)
Acta Ophthalmol
, vol.86
, pp. 35-41
-
-
Economou, M.A.1
Andersson, S.2
Vasilcanu, D.3
-
54
-
-
33644751770
-
The insulin-like growth factor-i receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells
-
Girnita A, All-Ericsson C, Economou MA, et al. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells. Clin Cancer Res. 2006;12:1383-1391.
-
(2006)
Clin Cancer Res
, vol.12
-
-
Girnita, A.1
All-Ericsson, C.2
Economou, M.A.3
-
55
-
-
79952672340
-
Clinical phase i study with an insulin-like growth factor-1 receptor inhibitor: Experiences in patients with squamous non-small cell lung carcinoma
-
Ekman S, Frödin JE, Harmenberg J, et al. Clinical phase I study with an insulin-like growth factor-1 receptor inhibitor: experiences in patients with squamous non-small cell lung carcinoma. Acta Oncol. 2011;50:441-447.
-
(2011)
Acta Oncol
, vol.50
, pp. 441-447
-
-
Ekman, S.1
Frödin, J.E.2
Harmenberg, J.3
-
56
-
-
79961004321
-
Signalling by insulin and igf receptors: Supporting acts and new players
-
Siddle K. Signalling by insulin and IGF receptors: supporting acts and new players. J Mol Endocrinol. 2011;47:R1-R10.
-
(2011)
J Mol Endocrinol
, vol.47
-
-
Siddle, K.1
-
57
-
-
52449092107
-
Breast tumor cells with pi3k mutation or her2 amplification are selectively addicted to akt signaling
-
She Q-B, Chandarlapaty S, Ye Q, et al. Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling. PLoS One. 2008;3:e3065.
-
(2008)
PLoS One
, vol.3
-
-
She, Q.-B.1
Chandarlapaty, S.2
Ye, Q.3
-
58
-
-
2942652871
-
Mechanisms of tamoxifen resistance: Increased estrogen receptor-her2/neu cross-talk in er/ her2-positive breast cancer
-
Shou J, Massarweh S, Osborne CK, et al. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/ HER2-positive breast cancer. J Natl Cancer Inst. 2004;96:926-935.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 926-935
-
-
Shou, J.1
Massarweh, S.2
Osborne, C.K.3
-
59
-
-
0032549570
-
Overexpression of egfr and c-erbb2 causes enhanced cell migration in human breast cancer cells and nih3t3 fibroblasts
-
Verbeek BS, Adriaansen-Slot SS, Vroom TM, Beckers T, Rijksen G. Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett. 1998;425:145-150.
-
(1998)
FEBS Lett
, vol.425
, pp. 145-150
-
-
Verbeek, B.S.1
Adriaansen-Slot, S.S.2
Vroom, T.M.3
Beckers, T.4
Rijksen, G.5
-
60
-
-
77951879658
-
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation
-
Zhang H, Fagan DH, Zeng X, Freeman KT, Sachdev D, Yee D. Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation. Oncogene. 2010;29:2517-2527.
-
(2010)
Oncogene
, vol.29
, pp. 2517-2527
-
-
Zhang, H.1
Fagan, D.H.2
Zeng, X.3
Freeman, K.T.4
Sachdev, D.5
Yee, D.6
|